Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-28

FDA Approved: CHLOROQUINE PHOSPHATE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approves Amneal Pharmaceuticals of New York LLC's supplemental application for chloroquine phosphate, granting approval of the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroquine phosphate (Chloroquine phosphate)

Snippet

SUPPL AP for CHLOROQUINE PHOSPHATE (CHLOROQUINE PHOSPHATE)